Dr. Shalini Ratnagiri, MD

Dr. Ratnagiri practices at MUSC Health Kershaw Medical Center in Camden, South Carolina, part of Medical University of South Carolina.

Dr. Ratnagiri's NPI, 1447771944, was assigned on July 5, 2017. Dr. Ratnagiri holds South Carolina license 83858.

Dr. Ratnagiri's primary practice is MUSC Health Kershaw Medical Center, at 1315 Roberts Street, Camden, SC 29020 in Kershaw County. The practice phone is (803) 432-4311.

Dr. Ratnagiri's primary practice is MUSC Health Kershaw Medical Center in Camden, South Carolina, part of Medical University of South Carolina. Dr. Ratnagiri is also affiliated with MUSC Health Columbia Medical Center Downtown. The medical group on file is Apogee Medical Group South Carolina. Dmand AI also links Dr. Ratnagiri to 1 more hospice, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ratnagiri practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ratnagiri's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ratnagiri is licensed in South Carolina.

CMS data shows 665 Medicare services from Dr. Ratnagiri across 5 procedure codes in 2024, for 206 Medicare patients. Medicare paid $53,298 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 206 Medicare patients who saw Dr. Ratnagiri in 2024. The largest group is 75 to 84, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ratnagiri's median patient age at 69, with 60% women.

In 2024, Dr. Ratnagiri wrote 278 Medicare Part D claims for 122 patients. 78% of them were for generic drugs. CMS names the drug for 69 of them, across 5 drugs with 11 or more claims each, at $875 in total drug cost. In 2023, CMS named 99 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Ratnagiri for performance year 2024, reported as part of a group. Dr. Ratnagiri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Ratnagiri from 4 drug and device companies from 2017 to 2020. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $206.